Genetic diagnostic technology a game changer for rare diseases, but ethics concerns linger – Euractiv
Genetic diagnostic technology advances for rare diseases offer hope, but gene-tech comes wrapped in complex ethical concerns. Currently, rare disease patients take an average of five years to get a diagnosis, with many misdiagnoses. So will Europe accelerate modern diagnostics, or will ethical concerns stifle innovation?
Around 30 million Europeans are living with a rare disease, and less than 5% of rare conditions are effectively treated. For rare diseases that do not present symptoms early on, newborn screening programs are important, especially when early intervention may prevent symptoms or disease progression, as EURORDIS-Rare Disease Europe points out.
“The best way…
Read More